1. Home
  2. FLGT vs ABL Comparison

FLGT vs ABL Comparison

Compare FLGT & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • ABL
  • Stock Information
  • Founded
  • FLGT 2011
  • ABL 2004
  • Country
  • FLGT United States
  • ABL United States
  • Employees
  • FLGT N/A
  • ABL N/A
  • Industry
  • FLGT Medical Specialities
  • ABL Investment Managers
  • Sector
  • FLGT Health Care
  • ABL Finance
  • Exchange
  • FLGT Nasdaq
  • ABL Nasdaq
  • Market Cap
  • FLGT 587.3M
  • ABL 521.6M
  • IPO Year
  • FLGT 2016
  • ABL N/A
  • Fundamental
  • Price
  • FLGT $18.07
  • ABL $4.92
  • Analyst Decision
  • FLGT Buy
  • ABL Strong Buy
  • Analyst Count
  • FLGT 2
  • ABL 4
  • Target Price
  • FLGT $24.00
  • ABL $13.13
  • AVG Volume (30 Days)
  • FLGT 210.6K
  • ABL 1.0M
  • Earning Date
  • FLGT 08-01-2025
  • ABL 08-07-2025
  • Dividend Yield
  • FLGT N/A
  • ABL N/A
  • EPS Growth
  • FLGT N/A
  • ABL N/A
  • EPS
  • FLGT N/A
  • ABL N/A
  • Revenue
  • FLGT $292,448,000.00
  • ABL $134,575,948.00
  • Revenue This Year
  • FLGT $11.79
  • ABL $68.84
  • Revenue Next Year
  • FLGT $10.45
  • ABL $26.84
  • P/E Ratio
  • FLGT N/A
  • ABL N/A
  • Revenue Growth
  • FLGT 1.71
  • ABL 73.39
  • 52 Week Low
  • FLGT $14.57
  • ABL $4.60
  • 52 Week High
  • FLGT $25.11
  • ABL $11.86
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 29.01
  • ABL 32.28
  • Support Level
  • FLGT $19.18
  • ABL $4.80
  • Resistance Level
  • FLGT $19.96
  • ABL $5.68
  • Average True Range (ATR)
  • FLGT 0.56
  • ABL 0.30
  • MACD
  • FLGT -0.15
  • ABL 0.04
  • Stochastic Oscillator
  • FLGT 0.86
  • ABL 24.60

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About ABL Abacus Life Inc.

Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.

Share on Social Networks: